Management of Loculated Effusions in the Right Lung
Insert a chest tube early with ultrasound guidance and administer intrapleural fibrinolytic therapy (alteplase, urokinase, or streptokinase) if simple drainage fails after 48 hours, with VATS reserved for cases that don't respond after approximately 7 days. 1, 2
Initial Assessment and Imaging
- Use transthoracic ultrasonography as your first-line imaging modality to identify septations, as it has 81-88% sensitivity and 83-96% specificity for detecting loculations 1
- Reserve CT scanning for mediastinal loculations or those involving fissures where ultrasound is limited by overlying lung 1
- Always use ultrasound guidance when performing any pleural intervention on loculated effusions, as this reduces complications and increases diagnostic yield 1
Treatment Algorithm Based on Effusion Size and Type
Small Effusions (<10 mm rim or <25% hemithorax)
- Treat with antibiotics alone without drainage if uncomplicated parapneumonic effusion 1
Moderate to Large Effusions
For Parapneumonic/Infected Loculated Effusions:
- Insert a small-bore chest tube (10-14F) immediately when loculation is identified, as loculated collections are associated with longer hospital stays and worse outcomes 1, 2
- Connect to underwater seal drainage initially without suction 2
- Apply high-volume, low-pressure suction (-10 to -20 cm H₂O) only after 48 hours if the collection persists 2
- Administer appropriate antibiotics (cefuroxime plus metronidazole, or benzylpenicillin plus ciprofloxacin) alongside drainage 1, 2
- Involve a respiratory physician or thoracic surgeon early, as specialist involvement reduces delays and morbidity 1
Adjunctive Fibrinolytic Therapy
Administer intrapleural fibrinolytics if simple drainage is inadequate after 48 hours 1, 2
Dosing options:
- Alteplase: 0.1 mg/kg once daily with 1-4 hour dwell time 1
- Urokinase: 100,000 IU once daily for 3 days 3
- Streptokinase: 250,000 IU twice daily for 3 days 3
Expected outcomes with fibrinolytics:
- Shorter hospital stays (6.2 vs 8.7 days compared to drainage alone) 1, 2, 3
- Increased fluid drainage in 93-100% of patients 1, 3
- 85% show >40% reduction in pleural opacity versus 35% with placebo 1, 3
- Avoidance of surgery in approximately 90% of cases 1
Safety profile:
- Bleeding complications occur in only 2-8.5% of patients 1, 3
- Alteplase is safer than streptokinase, which causes fever and systemic antibody responses 1
- Patients receiving streptokinase must be given an exposure card and should receive alternative agents for future systemic indications 3
Reassessment at 5-8 Days
Evaluate treatment effectiveness by looking for:
- Resolution of fever and sepsis 3
- Increased daily drainage output 3
- Radiographic improvement with reduction in pleural opacity 3
Surgical Intervention
Consider Video-Assisted Thoracoscopic Surgery (VATS) if medical management fails after approximately 7 days 1, 2
- VATS allows septations to be broken up under direct vision 1
- Randomized trials show similar outcomes between VATS and chest tube drainage with fibrinolytics 1
Special Considerations for Malignant Loculated Effusions
- Use an indwelling pleural catheter (IPC) as first-line therapy for symptomatic malignant pleural effusions with loculation 1
- IPCs allow ongoing drainage without requiring complete lung expansion 1
- Never attempt pleurodesis in patients with non-expandable lung due to loculations, as it will fail 1
- Fibrinolytics can be administered through IPCs to improve drainage but don't improve dyspnea or pleurodesis success rates in malignant effusions 1
Critical Pitfalls to Avoid
- Never rely solely on CT for detecting septations when ultrasound is available, as ultrasound is superior 1
- Never attempt pleurodesis with non-expandable lung 1
- Never delay drainage of large loculated effusions or those causing respiratory distress 1
- Never clamp a bubbling chest tube, as this can convert a simple pneumothorax into life-threatening tension pneumothorax 2
- Never perform pleural interventions in asymptomatic patients with malignant pleural effusion 1